Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Total net revenue | $ 75,808 | $ 79,950 | $ 152,837 | $ 163,457 | ||
| Operating expenses: | ||||||
| Cost of revenue | [1] | 11,112 | 10,950 | 22,259 | 22,885 | |
| Sales and marketing | [1] | 42,815 | 31,626 | 82,510 | 65,704 | |
| General and administrative | [1] | 22,693 | 19,744 | 46,860 | 37,072 | |
| Research and development | [1] | 2,721 | 2,141 | 5,046 | 4,487 | |
| Depreciation and amortization | 565 | 500 | 1,083 | 1,031 | ||
| Impairment of intangible assets | 0 | 0 | 0 | 380 | ||
| Related party expense | 158 | 178 | 431 | 307 | ||
| Total operating expenses | 80,064 | 65,139 | 158,189 | 131,866 | ||
| (Loss) income from operations | (4,256) | 14,811 | (5,352) | 31,591 | ||
| Other income, net | 1,182 | 343 | 1,276 | 501 | ||
| Interest income, net | 290 | 769 | 800 | 1,710 | ||
| (Loss) income before income taxes | (2,784) | 15,923 | (3,276) | 33,802 | ||
| Income tax (benefit) expense | (156) | 613 | (94) | 1,651 | ||
| Net (loss) income | (2,628) | 15,310 | (3,182) | 32,151 | ||
| Net (loss) income attributable to noncontrolling interests | (1,999) | 14,013 | (1,980) | 29,964 | ||
| Net (loss) income attributable to MarketWise, Inc. | $ (629) | $ 1,297 | $ (1,202) | $ 2,187 | ||
| Earnings per share – basic (USD per share) | $ (0.24) | $ 0.55 | $ (0.47) | $ 0.99 | ||
| Earnings per share – diluted (USD per share) | $ (0.24) | $ 0.53 | $ (0.47) | $ 0.95 | ||
| Weighted average shares outstanding – basic (in shares) | 2,643 | 2,357 | 2,554 | 2,205 | ||
| Weighted average shares outstanding – diluted (in shares) | 2,643 | 2,445 | 2,554 | 2,302 | ||
| Nonrelated Party | ||||||
| Total net revenue | $ 75,290 | $ 79,309 | $ 151,667 | $ 162,323 | ||
| Related Party | ||||||
| Total net revenue | $ 518 | $ 641 | $ 1,170 | $ 1,134 | ||
| ||||||
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|